SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under
Section 12(g) of the Securities Exchange Act of 1934 or
Suspension of Duty to File Reports Under Sections 13 and
15(d) of the Securities
Exchange Act of 1934.
Commission File Number 1-10538
Gamma Biologicals, Inc.
(Exact name of registrant as specified in its charter)
3700 Mangum Road, Houston, Texas 77092
(713) 681-8481 (Address, including zip code, and
telephone number, including area code,
of registrant's principal executive offices)
Common Stock Par Value $0.01 Per Share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [ ]
Approximate number of holders of record as of
the certification or notice date: 238
Pursuant to the requirements of the Securities Exchange Act of 1934,
Gamma Biologicals, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
DATE: December 18, 1998 BY: /s/ Edward L. Gallup
------------------ ----------------------
Edward L. Gallup
President and Chief Executive Officer
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
